Lancet iron study
This article was originally published in The Tan Sheet
Executive Summary
"Current guidelines for universal supplementation with iron and folic acid should be revised" because "routine supplementation with iron and folic acid in preschool children in a population with high rates of malaria can result in an increased risk of severe illness and death," according to a study published in The Lancet Jan. 14. Sunil Sazawaal, Johns Hopkins University, et al., conducted an 18-month randomized, double-masked, placebo-controlled trial in Pemba, Zanzibar on children aged one month to 4 years. "Midway through the trial, the iron and folic acid-containing groups had to be stopped because they were associated with higher rates of adverse events (hospital admissions and deaths) than the zinc and placebo groups," the authors state. International guidelines currently recommend supplementation in children younger than two-years-old who live in areas with a high prevalence of anemia, Sazawaal et al. note...
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.